Mary McManus

Mary McManus is a seasoned professional in clinical research and trial management, currently serving as Managing Partner at OWL Oncology Research since January 2022. McManus has extensive experience from previous roles, including Clinical Trial Manager Consultant at Harpoon Therapeutics and Senior Clinical Consultant at Merck, where responsibilities involved transferring clinical assets post-acquisition. At IQVIA, McManus held several positions, culminating in Associate Clinical Project Management Director, overseeing multiple global oncology trials. Earlier career milestones include leading clinical studies at Quintiles and QLT Inc., managing trials in oncology and dermatology, while ensuring compliance with GCP and regulatory standards. McManus holds a Bachelor of Science in Pre-Medicine from Southern Illinois University Edwardsville.